DUBLIN, May 24, 2021 /PRNewswire/ — The “Biosensors Market Size, Share & Trends Analysis Report by Application by Technology, by End-use, by Region, and Segment Forecasts, 2021-2028” report has been added to ResearchAndMarkets.com’s offering.
The global biosensors market size is anticipated to reach USD 41.8 billion by 2028 and is expected to expand at a CAGR of 7.9% from 2021 to 2028.
The rising prevalence of chronic conditions such as diabetes and obesity and the growing demand for early and accurate detection of any associated condition are the key driving factors for the market.
Furthermore, the outbreak of COVID-19 has drastically spurred the demand for point-of-care testing devices. FDA is giving fast-track approvals to the companies owing to the shortage of these devices globally.
For instance, in May 2020, Philips secured 510k FDA clearance for its wearable biosensor, which helps in managing confirmed and suspected cases of COVID-19 in hospitals, promoting biosensors technology and product development.
Moreover, rapid technological advancements are expected to be a significant factor for market growth over the forecast period. For instance, in June 2020, Abbott received the U.S. FDA clearance for its next-generation, integrated glucose monitor system- FreeStyle Libre 2 intended to measure diabetes in individuals aged 4 years and above and has an optional real-time alarm.
Biosensors Market Report Highlights
- On the basis of application, the medical segment dominated the market in 2020 with a revenue share of 66.6%. The device is considered an essential tool in the detection and monitoring of a wide range of medical conditions, such as diabetes and cancer.
- Based on technology, the electrochemical segment dominated the market in 2020 with a revenue share of 70.9% owing to its widespread applications for analysis in biochemical and biological processes.
- The home healthcare diagnostics segment is expected to witness the fastest growth rate over the forecast period owing to the high prevalence of chronic disease globally.
- North America dominated the market in 2020 with a revenue share of 39.9% owing to the presence of a highly developed healthcare infrastructure and favorable reimbursement policies in this region.
Market Dynamics
Market Driver Analysis
- Myriad Applications In The Medical Field
- Rising Diabetic Population Base
- High Demand For Miniature Diagnostic Devices
- Rapid Technological Advancements
Market Restraints Analysis
- High cost of R&D
- Unfavorable reimbursement policies of the Government
Biosensors: Market Analysis Tools
- Industry Analysis – Porter’s
- Pestle Analysis
- Major Deals And Strategic Alliances
- New Product Launch
- Acquisition
- Partnerships
- Market Entry Strategies
Competitive Analysis
- Azur Environmental
- Abbott
- Medtronic
- Biosensor Bv
- Bayer Ag
- Cranfield Biotechnology Centre
- Pinnacle Technologies Inc.
- Dupont Biosensor Materials
- Ercon, Inc.
- Eg & Ic Sensors Inc.
- Johnson & Johnson Inc.
- Innovative Biosensors Inc.
- Lifescan, Inc.
- Strategic Diagnostics Inc.
- Sysmex Corporation
- Roche Diagnostics
For more information about this report visit https://www.researchandmarkets.com/r/71lh9f
Media Contact:
Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1904
Fax (outside U.S.): +353-1-481-1716
View original content:SOURCE Research and Markets
